Ryoichi Ishitani

1.2k total citations
41 papers, 986 citations indexed

About

Ryoichi Ishitani is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Nutrition and Dietetics. According to data from OpenAlex, Ryoichi Ishitani has authored 41 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 7 papers in Nutrition and Dietetics. Recurrent topics in Ryoichi Ishitani's work include Neuroscience and Neuropharmacology Research (16 papers), Molecular Biology Techniques and Applications (10 papers) and RNA Interference and Gene Delivery (9 papers). Ryoichi Ishitani is often cited by papers focused on Neuroscience and Neuropharmacology Research (16 papers), Molecular Biology Techniques and Applications (10 papers) and RNA Interference and Gene Delivery (9 papers). Ryoichi Ishitani collaborates with scholars based in Japan, United States and Switzerland. Ryoichi Ishitani's co-authors include De‐Maw Chuang, Nobuo Katsube, Katsuyoshi Sunaga, Masaharu Tanaka, Atsushi Hirano, Paul A. Saunders, Katsumi Tsuchiya, Hisao Tajima, Hiroshi Takahashi and Akihisa Miyakawa and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ryoichi Ishitani

38 papers receiving 963 citations

Peers

Countries citing papers authored by Ryoichi Ishitani

Since Specialization

Citations

This map shows the geographic impact of Ryoichi Ishitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoichi Ishitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoichi Ishitani more than expected).

Fields of papers citing papers by Ryoichi Ishitani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryoichi Ishitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoichi Ishitani. The network helps show where Ryoichi Ishitani may publish in the future.

Co-authorship network of co-authors of Ryoichi Ishitani

This figure shows the co-authorship network connecting the top 25 collaborators of Ryoichi Ishitani. A scholar is included among the top collaborators of Ryoichi Ishitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryoichi Ishitani. Ryoichi Ishitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pro‐apoptotic protein glyceraldehyde‐3‐phosphate dehydrogenase promotes the formation of Lewy body‐like inclusions 2005 ·European Journal of Neuroscience ·Katsumi Tsuchiya, Hisao Tajima, Toyoyasu Kuwae, Takao Takeshima, Toshiya Nakano, Masaharu Tanaka, Katsuyoshi Sunaga, Yōko Fukuhara, Kenji Nakashima, Eisaku Ohama, Hideki Mochizuki, Yoshikuni Mizuno, Nobuo Katsube, Ryoichi Ishitani	53
2	Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: anti-dementia drugs depress its activation in apoptosis 2004 ·Life Sciences ·Katsumi Tsuchiya, Hisao Tajima, Mitsunori Yamada, Hitoshi Takahashi, Toyoyasu Kuwae, Katsuyoshi Sunaga, Nobuo Katsube, Ryoichi Ishitani	35
3	Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs 2003 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Ryoichi Ishitani, Hisao Tajima, H. Takata, Katsumi Tsuchiya, Toyoyasu Kuwae, Mitsunori Yamada, Hitoshi Takahashi, Nadine Tatton, Nobuo Katsube	41
4	GAPDH knockdown rescues mesencephalic dopaminergic neurons from MPP+-induced apoptosis 2001 ·Neuroreport ·Yōko Fukuhara, Takao Takeshima, Yoshihiro Kashiwaya, Kotaro Shimoda, Ryoichi Ishitani, Kenji Nakashima	39
5	A Review of the Neurotrophic and Neuroprotective Properties of ONO‐1603: Comparison with Those of Tetrahydroaminoacridine, an Antidementia Drug 2000 ·CNS Drug Reviews ·Nobuo Katsube, Ryoichi Ishitani	6
6	Over-expression of GAPDH induces apoptosis in COS-7 cells transfected with cloned GAPDH cDNAs 1999 ·Neuroreport ·Hisao Tajima, Katsumi Tsuchiya, M. Yamada, Kaoru Kondo, Nobuo Katsube, Ryoichi Ishitani	65
7	ONO-1603, a Potential Antidementia Drug, Delays Age-Induced Apoptosis and Suppresses Overexpression of Glyceraldehyde-3-Phosphate Dehydrogenase in Cultured Central Nervous System Neurons 1999 ·Journal of Pharmacology and Experimental Therapeutics ·Nobuo Katsube, (unknown), (unknown), De‐Maw Chuang, Ryoichi Ishitani	48
8	Nuclear Localization of Overexpressed Glyceraldehyde-3-Phosphate Dehydrogenase in Cultured Cerebellar Neurons Undergoing Apoptosis 1998 ·Molecular Pharmacology ·Ryoichi Ishitani, Masaharu Tanaka, Katsuyoshi Sunaga, Nobuo Katsube, De‐Maw Chuang	140
9	Overexpression of Glyceraldehyde-3-Phosphate Dehydrogenase Is Involved in Low K+-Induced Apoptosis but Not Necrosis of Cultured Cerebellar Granule Cells 1997 ·Molecular Pharmacology ·Ryoichi Ishitani, Katsuyoshi Sunaga, Masaharu Tanaka, (unknown), De‐Maw Chuang	62
10	Evidence that Glyceraldehyde‐3‐Phosphate Dehydrogenase Is Involved in Age‐Induced Apoptosis in Mature Cerebellar Neurons in Culture 1996 ·Journal of Neurochemistry ·Ryoichi Ishitani, Katsuyoshi Sunaga, Atsushi Hirano, Paul A. Saunders, Nobuo Katsube, De‐Maw Chuang	189
11	ONO-1603, a potential antidementia drug, shows neuroprotective effects and increases m3-muscarinic receptor mRNA levels in differentiating rat cerebellar granule neurons 1996 ·Neuroscience Letters ·Nobuo Katsube, Katsuyoshi Sunaga, De‐Maw Chuang, Ryoichi Ishitani	15
12	Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain 1995 ·Neuroscience Letters ·(unknown), Hiroshi Takahashi, De‐Maw Chuang, Ryoichi Ishitani	87
13	Tryptamine Induces Phosphoinositide Turnover and Modulates Adrenergic and Muscarinic Cholinergic Receptor Function in Cultured Cerebellar Granule Cells 1994 ·Journal of Neurochemistry ·Ryoichi Ishitani, Mitsutoshi Kimura, (unknown), De‐Maw Chuang	3
14	Autoradiographic demonstration of an increase in muscarinic cholinergic receptors in cerebellar granule cells treated with tetrahydroaminoacridine 1993 ·Neuroscience Letters ·(unknown), De‐Maw Chuang, Ryoichi Ishitani	6
15	TETRAHYDROAMINOACRIDINE SHOWS A TROPHIC EFFECT ON DIFFERENTIATING CEREBELLAR GRANULE CELLS 1992 ·Journal of Pharmacobio-Dynamics ·Katsuyoshi Sunaga, Ryoichi Ishitani	1
16	Effects of protein-modifying reagents on brain tryptamine binding sites: Possible involvement of a thiol group in temperature-induced high-affinity (3H)tryptamine binding sites. 1990 ·The Japanese Journal of Pharmacology ·(unknown), Michiko Saito, Ryoichi Ishitani	2
17	Glutaraldehyde pretreatment blocks temperature-induced high-affinity [3H]tryptamine binding 1988 ·Life Sciences ·(unknown), Ryoichi Ishitani	5
18	Implication of acidic lipids in 5-hydroxytryptamine receptor mechanisms 1985 ·Life Sciences ·(unknown), Ryoichi Ishitani	11
19	BUTANOL EXTRACTS FROM MYELIN FRAGMENTS: COLORIMETRIC ASSAY OF GANGLIOSIDES IN MYELIN BUTANOL EXTRACTS AND ITS BINDING CAPACITY FOR 5-HYDROXYTRYPTAMINE 1981 ·The Japanese Journal of Pharmacology ·Ryoichi Ishitani, (unknown), (unknown)	1
20	Studies on the Ultrastructural Distribution of H3-Dimetacrine in Rat Cerebral Cortex 1972 ·The Japanese Journal of Pharmacology ·Ryoichi Ishitani, Tetsuo Satoh, Tetsuya Suga, Haruo Kitagawa	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact